InvestorsHub Logo
icon url

ExtremelyBullishZig

01/30/23 1:41 PM

#400617 RE: bas2020 #400616

Credible to whom?
icon url

kund

01/30/23 1:46 PM

#400618 RE: bas2020 #400616

SA author is super pumper, he argues through comments...

Anavex will likely present and publish in a peer-reviewed journal the Phase 2b/3 data in Q1 2023. Emergency approval by the FDA could come in Q2 2023. I am thinking as early as May.



This "Political Economist" doesn't know how Misleading works, peer review by Q1 2023, may be he has typo, he means 2032....